BioLineRx and Hemispherian AS Highlight New Data on GLIX1 at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
Go back to BioLineRx and Hemispherian AS Highlight New Data on GLIX1 at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 3.26 +0.02 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.24 | 52 Week High | $1.63 | |||
| Open | $3.23 | 52 Week Low | $0.71 | |||
| Day High | $3.45 | P/E | N/A | |||
| Day Low | $3.23 | EPS | $0.00 | |||
| Volume | 74,144 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 3.26 +0.02 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.24 | 52 Week High | $1.63 | |||
| Open | $3.23 | 52 Week Low | $0.71 | |||
| Day High | $3.45 | P/E | N/A | |||
| Day Low | $3.23 | EPS | $0.00 | |||
| Volume | 74,144 | |||||

